L-ficolin and capsular polysaccharide-specific igg in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2053-2060

  Fujieda, Mioko ^a   Aoyagi, Youko ^a   Matsubara, Kousaku ^b   Takeuchi, Yasuhito ^b   Fujimaki, Wakae ^a   Matsushita, Misao ^c   Bohnsack, John F ^d   Takahashi, Shinji ^a  

^a KAGAWA NUTRITION UNIVERSITY   (Japan)

^b NISHI KOBE MEDICAL CENTER   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; FICOLIN; IMMUNOGLOBULIN G; POLYSACCHARIDE; BACTERIAL POLYSACCHARIDE; CAPSID PROTEIN; HEXON CAPSID PROTEIN, ADENOVIRUS; LECTIN; OPSONIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORD SERUM; IN VITRO STUDY; NONHUMAN; OPSONOPHAGOCYTOSIS; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS; ANTIBODY SPECIFICITY; BACTERIAL MEMBRANE; BLOOD; FETUS BLOOD; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; NEUTROPHIL; NEWBORN; PHYSIOLOGY; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

ANTIBODY SPECIFICITY; BACTERIAL CAPSULES; CAPSID PROTEINS; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; LECTINS; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

EID: 85047688162     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06232-11     Document Type: Article

References (39)

1. Aoyagi Y, et al. 2008. L-ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through Nacetylneuraminic acid of capsular polysaccharide and activate the complement pathway. Infect. Immun. 76:179 -188.
2. Aoyagi Y, et al. 2005. Role of L-ficolin/mannose-binding lectinassociated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J. Immunol. 174:418-425.
3. Baker CJ, Rench MA, McInnes P. 2003. Immunization of pregnant women with group B streptococcal type III capsular polysaccharidetetanus toxoid conjugate vaccine. Vaccine 21:3468 -3472.
4. Berenbaum MC. 1977. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin. Exp. Immunol. 28:1-18.
5. Bohnsack JF, et al. 2008. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. academic centers from 1995 to 1999. J. Clin. Microbiol. 46:1285-1291.
6. Chaffin DO, Mentele LM, Rubens CE. 2005. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J. Bacteriol. 187: 4615-4626.
7. Cheng Q, et al. 2001. Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. Infect. Immun. 69:2302-2308.
8. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL. 1980. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B streptococcus. J. Exp. Med. 151: 1275-1287.
9. Givner LB, Baker CJ, Edwards MS. 1987. Type III group B Streptococcus: functional interaction with IgG subclass antibodies. J. Infect. Dis. 155: 532-539.
10. Hoshina K, et al. 2002. Trend of neonatal group B streptococcal infection during the last 15 years. Pediatr. Int. 44:641- 646.
11. Hummelshøj T, et al. 2005. Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum. Mol. Genet. 14:1651-1658.
12. Jefferis R, Lund J, Pound JD. 1998. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol. Rev. 163:59 -76.
13. Jones N, et al. 2003. Multilocus sequence typing system for group B streptococcus. J. Clin. Microbiol. 41:2530 -2536.
14. Koenig JM, Keenan WJ. 2009. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr. Clin. North Am. 56: 689-708.
15. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. 2004. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279:47513- 47519.
16. Lachenauer CS, et al. 1999. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis. 179:1030 -1033.
17. Larsson C, et al. 2006. Association between low concentrations of antibodies to protein _ and Rib and invasive neonatal group B streptococcal infection. Arch. Dis. Child Fetal Neonatal Ed. 91:F403-F408.
18. Lin FY, et al. 2006. Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: a multicenter prospective study. J. Clin. Microbiol. 44:1257-1261.
19. Lin FY, et al. 2001. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J. Infect. Dis. 184:1022-1028.
20. Lin FY, et al. 2004. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J. Infect. Dis. 190:928 -934.
21. Manning SD, et al. 2009. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J. Clin. Microbiol. 47:1143-1148.
22. Manning SD, et al. 2006. Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies. Vaccine 24:6905- 6912.
23. Matsubara K, et al. 2002. Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan. J. Infect. Dis. 186:855- 858.
24. Matsushita M. 2010. Ficolins: complement-activating lectins involved in innate immunity. J. Innate Immun. 2:24 -32.
25. Matsushita M, Fujita T. 2001. Ficolins and the lectin complement pathway. Immunol. Rev. 180:78-85.
26. Matsushita M, Fujita T. 2002. The role of ficolins in innate immunity. Immunobiology 205:490-497.
27. Mayer MM. 1961. Complement and complement fixation. Hemolytic assay of complement, p 135-139. In Kabat EA, Mayer MM (ed), Experimental immunochemistry, 2nd ed. Charles C. Thomas, Springfield, IL.
28. Munthe-Fog L, et al. 2007. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand. J. Immunol. 65:383-392.
29. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK. 1989. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B streptococcus) causing invasive neonatal disease. Proc. Natl. Acad. Sci. U. S. A. 86:4731- 4735.
30. Nagano Y, et al. 1991. Restriction endonuclease digest patterns of chromosomal DNA from group B _-haemolitic streptococci. J. Med. Microbiol. 35:297-303.
31. Noya FJD, Baker CJ, Edwards MS. 1993. Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci. Infect. Immun. 61:1415-1420.
32. Pannaraj PS, et al. 2007. Group B Streptococcus bacteremia elicits _ C protein-specific IgM and IgG in humans. J. Infect. Dis. 195:353-356.
33. Schuchat A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
34. Swierzko AS, et al. 2009. Two factors of the lectin pathway of complement, L-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates. Mol. Immunol. 46:551-558.
35. Takahashi S, et al. 1998. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J. Infect. Dis. 177:1116 -1119.
36. Takahashi S, et al. 2002. Correlation of phylogenetic lineages of group B streptococci, identified by analysis of restriction digest patterns of genomic DNA, with infB alleles and mobile genetic elements. J. Infect. Dis. 186:1034 -1038.
37. Takahashi S, Aoyagi Y, Adderson EE, Okuwaki Y, Bohnsack JF. 1999. Capsular sialic acid limits C5a production on type III group B streptococci. Infect. Immun. 67:1866 -1870.
38. Takahashi S, et al. 1995. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing. Infect. Immun. 63:4764-4769.
39. Wessels MR, et al. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U. S. A. 92:11490 -11494.